1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc

New York, NY, based Investment company Orbimed Advisors Llc buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Rhythm Pharmaceuticals Inc, scPharmaceuticals Inc, DaVita Inc, Nevro Corp, ACADIA Pharmaceuticals Inc, Arsanis Inc, Assembly Biosciences Inc, sells Incyte Corp, Aetna Inc, Biogen Inc, Merck Inc, Gilead Sciences Inc during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, Orbimed Advisors Llc. As of 2017-12-31, Orbimed Advisors Llc owns 126 stocks with a total value of $7.9 billion. These are the details of the buys and sells.

For the details of ORBIMED ADVISORS LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=ORBIMED+ADVISORS+LLC

These are the top 5 holdings of ORBIMED ADVISORS LLC
  1. Biogen Inc (BIIB) - 1,230,700 shares, 4.99% of the total portfolio. Shares reduced by 24.5%
  2. Alexion Pharmaceuticals Inc (ALXN) - 2,879,575 shares, 4.38% of the total portfolio. Shares reduced by 21.01%
  3. Regeneron Pharmaceuticals Inc (REGN) - 854,600 shares, 4.09% of the total portfolio. Shares added by 49.20%
  4. Celgene Corp (CELG) - 3,062,850 shares, 4.06% of the total portfolio. Shares reduced by 8.63%
  5. Vertex Pharmaceuticals Inc (VRTX) - 1,741,300 shares, 3.32% of the total portfolio. Shares reduced by 16.05%
New Purchase: Amicus Therapeutics Inc (FOLD)

Orbimed Advisors Llc initiated holding in Amicus Therapeutics Inc. The purchase prices were between $12.51 and $16.24, with an estimated average price of $13.74. The stock is now traded at around $15.04. The impact to a portfolio due to this purchase was 1.02%. The holding were 5,572,500 shares as of 2017-12-31.

New Purchase: Rhythm Pharmaceuticals Inc (RYTM)

Orbimed Advisors Llc initiated holding in Rhythm Pharmaceuticals Inc. The purchase prices were between $22 and $30.51, with an estimated average price of $26.41. The stock is now traded at around $27.34. The impact to a portfolio due to this purchase was 0.55%. The holding were 2,901,295 shares as of 2017-12-31.

New Purchase: scPharmaceuticals Inc (SCPH)

Orbimed Advisors Llc initiated holding in scPharmaceuticals Inc. The purchase prices were between $11.8 and $17.31, with an estimated average price of $14.03. The stock is now traded at around $16.72. The impact to a portfolio due to this purchase was 0.52%. The holding were 3,409,865 shares as of 2017-12-31.

New Purchase: DaVita Inc (DVA)

Orbimed Advisors Llc initiated holding in DaVita Inc. The purchase prices were between $53.89 and $72.36, with an estimated average price of $61.55. The stock is now traded at around $72.26. The impact to a portfolio due to this purchase was 0.44%. The holding were 477,400 shares as of 2017-12-31.

New Purchase: ACADIA Pharmaceuticals Inc (ACAD)

Orbimed Advisors Llc initiated holding in ACADIA Pharmaceuticals Inc. The purchase prices were between $26.84 and $39.14, with an estimated average price of $32.01. The stock is now traded at around $25.89. The impact to a portfolio due to this purchase was 0.33%. The holding were 849,100 shares as of 2017-12-31.

New Purchase: Arsanis Inc (ASNS)

Orbimed Advisors Llc initiated holding in Arsanis Inc. The purchase prices were between $10.87 and $18.48, with an estimated average price of $13.95. The stock is now traded at around $18.23. The impact to a portfolio due to this purchase was 0.3%. The holding were 1,868,966 shares as of 2017-12-31.

Added: Regeneron Pharmaceuticals Inc (REGN)

Orbimed Advisors Llc added to a holding in Regeneron Pharmaceuticals Inc by 49.20%. The purchase prices were between $358.63 and $469.95, with an estimated average price of $405.7. The stock is now traded at around $344.55. The impact to a portfolio due to this purchase was 1.35%. The holding were 854,600 shares as of 2017-12-31.

Added: Loxo Oncology Inc (LOXO)

Orbimed Advisors Llc added to a holding in Loxo Oncology Inc by 5345.60%. The purchase prices were between $73.62 and $94.01, with an estimated average price of $83.48. The stock is now traded at around $129.00. The impact to a portfolio due to this purchase was 0.99%. The holding were 94,100,036 shares as of 2017-12-31.

Added: Nevro Corp (NVRO)

Orbimed Advisors Llc added to a holding in Nevro Corp by 81.41%. The purchase prices were between $65.94 and $93.31, with an estimated average price of $80.08. The stock is now traded at around $86.82. The impact to a portfolio due to this purchase was 0.35%. The holding were 897,791 shares as of 2017-12-31.

Added: Assembly Biosciences Inc (ASMB)

Orbimed Advisors Llc added to a holding in Assembly Biosciences Inc by 60.16%. The purchase prices were between $28.58 and $48.15, with an estimated average price of $37.53. The stock is now traded at around $63.84. The impact to a portfolio due to this purchase was 0.26%. The holding were 1,198,026 shares as of 2017-12-31.

Added: Deciphera Pharmaceuticals Inc (DCPH)

Orbimed Advisors Llc added to a holding in Deciphera Pharmaceuticals Inc by 198.29%. The purchase prices were between $16.54 and $24.2, with an estimated average price of $19.58. The stock is now traded at around $23.70. The impact to a portfolio due to this purchase was 0.23%. The holding were 1,176,070 shares as of 2017-12-31.

Added: Envision Healthcare Corp (EVHC)

Orbimed Advisors Llc added to a holding in Envision Healthcare Corp by 98.64%. The purchase prices were between $24.79 and $45.13, with an estimated average price of $35.02. The stock is now traded at around $43.51. The impact to a portfolio due to this purchase was 0.19%. The holding were 875,400 shares as of 2017-12-31.

Sold Out: Incyte Corp (INCY)

Orbimed Advisors Llc sold out a holding in Incyte Corp. The sale prices were between $93.56 and $116.6, with an estimated average price of $104.61.

Sold Out: Mallinckrodt PLC (MNK)

Orbimed Advisors Llc sold out a holding in Mallinckrodt PLC. The sale prices were between $19.98 and $38.87, with an estimated average price of $26.89.

Sold Out: Synergy Pharmaceuticals Inc (SGYP)

Orbimed Advisors Llc sold out a holding in Synergy Pharmaceuticals Inc. The sale prices were between $1.84 and $3.46, with an estimated average price of $2.49.

Sold Out: Spark Therapeutics Inc (ONCE)

Orbimed Advisors Llc sold out a holding in Spark Therapeutics Inc. The sale prices were between $44.76 and $89.37, with an estimated average price of $72.05.

Sold Out: Dimension Therapeutics Inc (DMTX)

Orbimed Advisors Llc sold out a holding in Dimension Therapeutics Inc. The sale prices were between $5.9 and $6, with an estimated average price of $5.97.

Sold Out: Intercept Pharmaceuticals Inc (ICPT)

Orbimed Advisors Llc sold out a holding in Intercept Pharmaceuticals Inc. The sale prices were between $58.2 and $72.76, with an estimated average price of $63.09.

Reduced: Aetna Inc (AET)

Orbimed Advisors Llc reduced to a holding in Aetna Inc by 67.95%. The sale prices were between $151.44 and $182.73, with an estimated average price of $171.68. The stock is now traded at around $177.07. The impact to a portfolio due to this sale was -1.45%. Orbimed Advisors Llc still held 447,552 shares as of 2017-12-31.

Reduced: Biogen Inc (BIIB)

Orbimed Advisors Llc reduced to a holding in Biogen Inc by 24.5%. The sale prices were between $307.64 and $344.58, with an estimated average price of $320.78. The stock is now traded at around $279.90. The impact to a portfolio due to this sale was -1.2%. Orbimed Advisors Llc still held 1,230,700 shares as of 2017-12-31.

Reduced: Merck & Co Inc (MRK)

Orbimed Advisors Llc reduced to a holding in Merck & Co Inc by 33.93%. The sale prices were between $54.1 and $64.6, with an estimated average price of $58.15. The stock is now traded at around $55.36. The impact to a portfolio due to this sale was -1.14%. Orbimed Advisors Llc still held 3,625,400 shares as of 2017-12-31.

Reduced: Gilead Sciences Inc (GILD)

Orbimed Advisors Llc reduced to a holding in Gilead Sciences Inc by 72.95%. The sale prices were between $71.15 and $83.52, with an estimated average price of $75.96. The stock is now traded at around $81.06. The impact to a portfolio due to this sale was -1.09%. Orbimed Advisors Llc still held 521,600 shares as of 2017-12-31.

Reduced: Alexion Pharmaceuticals Inc (ALXN)

Orbimed Advisors Llc reduced to a holding in Alexion Pharmaceuticals Inc by 21.01%. The sale prices were between $106.78 and $143.84, with an estimated average price of $121.98. The stock is now traded at around $127.08. The impact to a portfolio due to this sale was -1.03%. Orbimed Advisors Llc still held 2,879,575 shares as of 2017-12-31.

Reduced: Boston Scientific Corp (BSX)

Orbimed Advisors Llc reduced to a holding in Boston Scientific Corp by 22.47%. The sale prices were between $24.79 and $29.8, with an estimated average price of $27.6. The stock is now traded at around $28.54. The impact to a portfolio due to this sale was -0.84%. Orbimed Advisors Llc still held 10,386,600 shares as of 2017-12-31.



Here is the complete portfolio of ORBIMED ADVISORS LLC. Also check out:

1. ORBIMED ADVISORS LLC's Undervalued Stocks
2. ORBIMED ADVISORS LLC's Top Growth Companies, and
3. ORBIMED ADVISORS LLC's High Yield stocks
4. Stocks that ORBIMED ADVISORS LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


alecmazototal yield 3.5%
alecmazoAlec Jun 19 2018
msacaccioStrong Comp Moats
acfinance2018New Filter Value + Growth + Ev
acfinance2018New Filter Value + Growth
BBotwinFCF
mjspencerdiv incr no debt
ahmedhashim100Screen 6
aboer52AB Basic DN <6<6 Benish>-5 AZ<
y.dimitrovinsider buying
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK